Product Name:5H-Pyrido[3,2-b]indole-7-carboxylic acid,3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-[phenyl(tetrahydro-2H-pyran-4-yl)methyl]-,methyl ester

IUPAC Name:methyl 3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-[(oxan-4-yl)(phenyl)methyl]-5H-pyrido[3,2-b]indole-7-carboxylate

CAS:1800345-34-9
Molecular Formula:C29H29N5O3
Purity:95%+
Catalog Number:CM665093
Molecular Weight:495.58

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1800345-34-9
Molecular Formula:C29H29N5O3
Melting Point:-
Smiles Code:COC(=O)C1=CC2=C(C=C1)C1=NC=C(C=C1N2C(C1CCOCC1)C1=CC=CC=C1)C1=C(C)N=NN1C
Density:
Catalog Number:CM665093
Molecular Weight:495.58
Boiling Point:
MDL No:
Storage:

Category Infos

Azaindoles
Azaindole can be regarded as the biological isostere of indole, and the molecular unit of indole plays a huge role in the life process. Many drug molecules contain indole units. Azaindole is an important heterocyclic intermediate with good biological and medicinal value, and is the core structure of many drugs, such as antitumor drugs, dopamine D4 receptors, kinase inhibitors, thrombin inhibitors, etc. Therefore, it has a wide range of application value in medical research. Azaindole can be regarded as the biological isostere of indole, and the molecular unit of indole plays a huge role in the life process. Many drug molecules contain indole units. Azaindole is an important heterocyclic intermediate with good biological and medicinal value, and is the core structure of many drugs, such as antitumor drugs, dopamine D4 receptors, kinase inhibitors, thrombin inhibitors, etc. Therefore, it has a wide range of application value in medical research.Azaindole
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.